Pakistan's drug regulator greenlit the country's first Phase 3 clinical trial for a potential COVID-19 vaccine, which is being developed by China's CanSino Biologics (CanSino) and Beijing Institute of Biotechnology. Government-run National Institute of Health (NIH) will be leading the trial
ISLAMABAD - Pakistan's drug regulator greenlit the country's first Phase 3 clinical trial for a potential COVID-19 vaccine, which is being developed by China's CanSino Biologics and Beijing Institute of Biotechnology.Government-run National Institute of Health will be leading the trial for the candidate Ad5-nCoV along with pharmaceutical company AJM - the local representative of CanSino.
CanSino last month said it was in talks for opportunities to launch Phase 3 trials in Saudi Arabia, Russia, Brazil and Chile. "DRAP has approved a target Group of 10,000 participants for our clinical trial," Hassan Abbas Zaheer, the coordinator of the trials for AJM, told Reuters via email.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Surge in cases in countries that contained coronavirus in early months signals move to new phase, says WHOSINGAPORE - The recent surge in cases in countries that had managed to contain the Covid-19 pandemic in its early months, actually marks their move to a new phase for which they are better prepared, said a senior World Health Organisation official.. Read more at straitstimes.com.
Read more »
Surge in cases in countries that contained virus in early months signals move to new phase, says WHOSINGAPORE - The recent surge in cases in countries that had managed to contain the Covid-19 pandemic in its early months, actually marks their move to a new phase for which they are better prepared, said a senior World Health Organisation official.. Read more at straitstimes.com.
Read more »
Britain encourages at-risk groups to sign up for Covid-19 vaccine trialsLONDON (REUTERS) - Britain on Monday (Aug 17) urged elderly people and volunteers from Black and Asian minority groups to sign up to a Covid-19 vaccine trial registry to boost efforts to find a working vaccine against the disease that offers protection against higher risk groups.. Read more at straitstimes.com.
Read more »
Testing of CanSino's COVID-19 candidate vaccine begins in RussiaMOSCOW: A late-stage trial of a COVID-19 candidate vaccine from CanSino Biologics has started in Russia, registration records showed, as the ...
Read more »
China grants country's first COVID-19 vaccine patent to CanSino: ReportChina's vaccine specialist CanSino Biologics Inc has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media ...
Read more »
Novavax begins mid-stage study of COVID-19 vaccine in South AfricaJOHANNESBURG: US drug developer Novavax said on Monday (Aug 17) that it is starting a mid-stage study of its experimental COVID-19 vaccine in ...
Read more »